DAVIS SELECTED ADVISERSDAVIS SELECTED ADVISERS

Institutional investor · Portfolio as of Q4 2024

SEC EDGAR SourceSEC Filings

Top Holdings100 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

CAPITAL ONE FINANCIAL CORP

9.2M$1.6B9.6%$70.15+150.44%
24 qtrssince 2019-Q1
Decreased
0

META PLATFORMS INC-CLASS A

2.5M$1.5B8.5%$151.75+288.39%
24 qtrssince 2019-Q1
Decreased
0

BERKSHIRE HATHAWAY INC-CL A

1,582$1.1B6.3%$301,215.00+125.13%
24 qtrssince 2019-Q1
Decreased
0

AMAZON.COM INC

3.8M$835.3M4.9%$100.45+120.32%
24 qtrssince 2019-Q1
Decreased
0

VIATRIS INC

62.6M$779M4.5%$11.30+4.27%
17 qtrssince 2020-Q4
Decreased
0

APPLIED MATERIALS INC

4.7M$766.3M4.5%$53.52+202.74%
24 qtrssince 2019-Q1
Increased
66

MGM RESORTS INTERNATIONAL

19.9M$690.3M4.0%$38.70-11.23%
6 qtrssince 2023-Q3
Increased
61

US BANCORP

14.4M$687.6M4.0%$33.25+37.51%
24 qtrssince 2019-Q1
Decreased
0

MARKEL CORP

370,522$639.6M3.7%$1,265.67+36.31%
24 qtrssince 2019-Q1
Increased
72

WELLS FARGO & CO

8.6M$606.5M3.5%$32.92+105.45%
24 qtrssince 2019-Q1
Decreased
0

HUMANA INC

2.3M$572.6M3.3%$341.15-26.75%
23 qtrssince 2019-Q2
Decreased
0

ALPHABET INC-CL A

3M$570.9M3.3%$94.65+101.25%
24 qtrssince 2019-Q1
Decreased
0

CVS HEALTH CORPORATION

11.4M$511.1M3.0%$42.28-0.52%
24 qtrssince 2019-Q1
Increased
87

TECK RESOURCES LTD-CLS B

11.3M$457.9M2.7%$27.29+46.83%
14 qtrssince 2021-Q3
Decreased
0

TEXAS INSTRUMENTS INC

2.4M$440.7M2.6%$86.64+106.14%
24 qtrssince 2019-Q1
Decreased
0

THE CIGNA GROUP

1.4M$395.4M2.3%$189.75+42.08%
24 qtrssince 2019-Q1
Decreased
0

QUEST DIAGNOSTICS INC

2.4M$361.7M2.1%$101.61+45.17%
24 qtrssince 2019-Q1
Decreased
0

SOLVENTUM CORP-W/I

5.2M$346.6M2.0%$53.18+24.20%
3 qtrssince 2024-Q2
Decreased
0

BERKSHIRE HATHAWAY INC-CL B

717,513$325.2M1.9%$200.27+125.77%
24 qtrssince 2019-Q1
Decreased
0

OWENS CORNING NEW

1.8M$308.5M1.8%$71.80+128.18%
24 qtrssince 2019-Q1
Decreased
0
$17.2B
AUM
100
Positions
Q4 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
-3%Q3'23$15.9B+11%Q4'23$17.7B+1%Q1'24$17.8B-4%Q2'24$17.2B+4%Q3'24$17.8B-3%Q4'24$17.2B
Activity profile
$ moved · Q4'24
New3%Increased28%Decreased68%Exited1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.7 years
<1Q2%1-4Q6%1-2Y4%2Y+88%

DAVIS SELECTED ADVISERS manages $17.2B across 100 positions as of Q4 2024. Top holdings: COF (9.6%), META (8.5%), BRK/A (6.3%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2/5.0.

Q4 2024 Summary

Added 2 new positions, exited 4, increased 28, trimmed 63. Top move: CVS (INCREASED, conviction 87). Portfolio: $17.2B across 100 positions.

Top holdings by portfolio weight

Total AUM$17B
COF9.59%
META8.48%
BRK/A6.26%
AMZN4.85%
VTRS4.53%
AMAT4.45%
MGM4.01%
USB4.00%
MKL3.72%
WFC3.52%
Other3.33%

Portfolio allocation by GICS sector

Sectors11
Financial Services35.93%
Healthcare17.39%
Communication Services13.49%
Consumer Cyclical11.59%
Technology8.65%
Industrials3.33%
Basic Materials2.66%
Unknown2.46%
Real Estate2.22%
Consumer Defensive1.49%
Other0.79%

Behavioral investing profile

7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction41
Concentration73
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
COPCOPCONOCOPHILLIPS
Q1 2025 Q2 2026+506,810 shares+$59.3M
4Q
CICITHE CIGNA GROUP
Q3 2025 Q2 2026+1.6M shares+$404.4M
4Q
NVDANVDANVIDIA CORP
Q3 2025 Q2 2026+65,592 shares+$16.9M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used